Trend-Following Backtester · Guide · backtest 한국어

equity · US

Avita Medical, Inc. backtest

10 trend-following strategies were compared on the full daily history of Avita Medical, Inc.. 7 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 7.5%, MDD -47.0%).

Data 2012-05-14 ~ 2026-07-31daily bars 3,574 (14.2 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

7 of 10 beat buy and hold (CAGR -11.5%, drawdown -94.1%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 7.5%, MDD -47.0%, Sharpe 0.38, 11% exposure.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 19.0%p higher than buy and hold, while drawdown improves by 47.1%p (CAGR 7.5%, MDD -47.0%, exposure 11%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=33, threshold=20
7.5%-47.0%0.380.162.8x2011%
볼린저 밴드 돌파
n=31, k=3.5
6.3%-49.5%0.360.132.4x208%
SMA 크로스오버
fast=58, slow=215
4.6%-85.0%0.320.051.9x1931%
EMA 크로스오버
fast=53, slow=212
3.1%-80.3%0.290.041.5x1228%
Keltner 채널 돌파
emaPeriod=33, atrPeriod=16, mult=4
4.1%-54.3%0.270.081.8x3013%
ROC 모멘텀
n=142, threshold=0.11
1.2%-78.1%0.230.021.2x11527%
Donchian 채널 돌파
entryN=97, exitN=73
-2.3%-66.8%0.16-0.030.7x2033%
Parabolic SAR
step=0.03, maxStep=0.18
-11.9%-92.5%0.03-0.130.2x31943%
Supertrend
period=13, mult=4.8
-12.2%-87.3%-0.00-0.140.2x5748%
MACD
fast=11, slow=42, signal=11
-13.5%-87.4%-0.01-0.150.1x25449%
Buy and hold-11.5%-94.1%0.20-0.120.2x1100%
1x 2013 2015 2017 2019 2021 2023 2025 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -24% -47% -71% -94% 2013 2015 2017 2019 2021 2023 2025 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -47.0% (2016-10-27 → 2019-01-29), recovered after 875 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next